Application of PCNE classification system in pharmaceutical monitoring of patients with respiratory diseases
10.12173/j.issn.1008-049X.202312034
- VernacularTitle:运用PCNE分类系统对呼吸道疾病患者进行药学监护的应用研究
- Author:
Man KANG
1
;
Xian ZHANG
;
Mingwei LI
;
Hua ZHANG
;
Jing XU
;
Xiaojuan WANG
Author Information
1. 安徽理工大学第一附属医院(淮南市第一人民医院)药学部(安徽淮南 232007)
- Keywords:
Drug-related problems;
European Pharmaceutical Care Network Classification System;
Pharmaceutical care;
Clinical pharmacist
- From:
China Pharmacist
2024;27(2):336-344
- CountryChina
- Language:Chinese
-
Abstract:
Objective To provide pharmaceutical monitoring using the Pharmaceutical Care Network Europe(PCNE)for patients with respiratory diseases,to explore effective pharmaceutical monitoring models in the department of respiratory,and to promote clinical rational drug use.Methods Inpatients diagnosed with chronic obstructive pulmonary disease(COPD)and lung infections in 2022 at the First Affiliated Hospital of Anhui University of Science and Technology were selected and divided into a simple group and an intervention group.According to the PCNE classification system,the types,causes,interventions,acceptance of interventions,and resolution status of drug-related problems(DRPs)were analyzed.Results A total of 120 cases were included,60 cases in the simple group and 60 cases in the intervention group.Regarding the number of DRPs,there were 15 cases in the simple group and 45 cases in the intervention group,and there was a significant difference between the two groups(P<0.05).There were a total of 82 DRPs,which were mainly related to therapeutic efficacy(51.22%)and safety(46.34%),and the reasons for this were that patients'incorrect medication usage method,inappropriate usage and dosage,and unscheduled safety monitoring,etc.The pharmacist interventions were 75(91.46%)at the drug level,38(46.34%)at the physician level,and 43(52.44%)at the patient level;after the pharmacist interventions,the acceptance rate was in the range of 97.56%,and 74.39%of the DRPs were resolved.Conclusion PCNE classification system helps clinical pharmacists to enhance their ability to find and deal with DRPs,reduce the risk of clinical adverse events and promote reasonable and safe drug use.Meanwhile,it is conducive to the standardization of pharmaceutical care records for patients with respiratory diseases and provides reference for pharmaceutical service models for patients in the department of respiratory.
